Author:
Ferrari S.,Sassoli V.,Orlandi M.,Strazzari S.,Puggioli C.,Battistini A.,Bacci G.
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Reference18 articles.
1. Bacci G, Picci P, Ruggieri P, et al. Primary chemotherapy and delayed surgery (Neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Rizzoli experience in 127 patients treated preoperatively with methotrexate i.v. (high vs moderate dose) and cisplatinum i.a. Cancer 1990; 65: 2539–2553.
2. Bacci G, Picci P, Pignatti G, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities. Clin Orthoped 1991; 270: 87–98.
3. Goorin AM, Perez-Atayde A, Gebhardt M, et al. Weekly high-dose methotrexate and doxorubicin for osteosarcoma. The Dana-Farber Cancer Institute/the Children's Hospital Study III. J Clin Oncol 1987; 5: 1178–1184.
4. Jaffe N, Raymond K, Ayala A, et al. Intraarterial cisdiammine -dichloroplatinum II in pediatric osteosarcoma: relationship of the effect on primary tumor to survival. In: Ryan JR, Baker O: Recent concepts in sarcoma treatment. Kluver Academic Publisher 275–282, 1988.
5. Kalifa C, Mlika N, Dubosset J, et al. The experience of T10 protocol in the pediatric department of the Goustave Roussy Institute. In Ryan JR, Baker O eds. Recent concepts in sarcoma treatment. Kluver Academic Publisher 1988: 301–305.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献